Will Africans take COVID-19 vaccination?
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The economic and humanistic impact of COVID-19 pandemic is enormous globally. No definitive treatment exists, hence accelerated development and approval of COVID-19 vaccines, offers a unique opportunity for COVID-19 prevention and control. Vaccine hesitancy may limit the success of vaccine distribution in Africa, therefore we assessed the potentials for coronavirus vaccine hesitancy and its determinants among Africans. An online cross-sectional African-wide survey was administered in Arabic, English, and French languages. Questions on demographics, self-reported health status, vaccine literacy, knowledge and perception on vaccines, past experience, behavior, infection risk, willingness to receive and affordability of the SARS-COV-2 vaccine were asked. Data were subjected to descriptive and inferential statistics. A total of 5,416 individuals completed the survey. Approximately, 94% were residents of 34 African countries while the other Africans live in the Diaspora. Only 63% of all participants surveyed were willing to receive the COVID-19 vaccination as soon as possible and 79% were worried about its side effects. Thirty-nine percent expressed concerns of vaccine-associated infection. The odds of vaccine hesitancy was 0.28 (95% CI: 0.22, 0.30) among those who believed their risk of infection was very high, compared to those who believed otherwise. The odds of vaccine hesitancy was one-fifth (OR = 0.21, 95% CI: 0.16, 0.28) among those who believed their risk of falling sick was very high, compared to those who believed their risk of falling very sick was very low. The OR of vaccine hesitancy was 2.72 (95% CI: 2.24, 3.31) among those who have previously refused a vaccine for themselves or their child compared to counterparts with no self-reported history of vaccine hesitancy. Participants want the vaccines to be mandatory (40%), provided free of charge (78%) and distributed in homes and offices (44%). COVID-19 vaccine hesitancy is substantial among Africans based on perceived risk of coronavirus infection and past experiences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cook, R. J., Dickens, B. M., & Fathalla, M. F. (2003) · Reproductive Health and Human Rights · doi:10.1093/acprof:oso/9780199241323.003.0025 · Cited by 10,769
A global survey of potential acceptance of a COVID-19 vaccine
Lazarus, J. V., Ratzan, S. C., Palayew, A., Gostin, L. O., Larson, H. J., Rabin, K., Kimball, S., & El-Mohandes, A. (2021) · Nature Medicine · doi:10.1038/s41591-020-1124-9 · Cited by 2,904
COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates
Sallam, M. (2021) · Vaccines · doi:10.3390/vaccines9020160 · Cited by 2,128
COVID-19–Related Infodemic and Its Impact on Public Health: A Global Social Media Analysis
Islam, M. S., Sarkar, T., Khan, S. H., Mostofa Kamal, A.-H., Hasan, S. M. M., Kabir, A., Yeasmin, D., Islam, M. A., Amin Chowdhury, K. I., Anwar, K. S., et al. (2020) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-0812 · Cited by 1,178
Planning for a COVID-19 Vaccination Program
Schaffer DeRoo, S., Pudalov, N. J., & Fu, L. Y. (2020) · JAMA · doi:10.1001/jama.2020.8711 · Cited by 608
Fearing the disease or the vaccine: The case of COVID-19
Karlsson, L. C., Soveri, A., Lewandowsky, S., Karlsson, L., Karlsson, H., Nolvi, S., Karukivi, M., Lindfelt, M., & Antfolk, J. (2021) · Personality and Individual Differences · doi:10.1016/j.paid.2020.110590 · Cited by 491
Saied, S. M., Saied, E. M., Kabbash, I. A., & Abdo, S. A. E. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26910 · Cited by 464
Kabamba Nzaji, M., Kabamba Ngombe, L., Ngoie Mwamba, G., Banza Ndala, D. B., Mbidi Miema, J., Luhata Lungoyo, C., Lora Mwimba, B., Cikomola Mwana Bene, A., & Mukamba Musenga, E. (2020) · Pragmatic and Observational Research · doi:10.2147/por.s271096 · Cited by 411
COVID-19 vaccines: The status and perspectives in delivery points of view
Chung, J. Y., Thone, M. N., & Kwon, Y. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.011 · Cited by 375
Research works printed but not linked: 2
- World Health Organization (WHO). REPORT OF THE SAGE WORKING GROUP ON VACCINE HESITANCY. 2014.
- University of Oxford. Our World in Data 2021 [18 March, 2021]. https://ourworldindata.org/covid-vaccinations.
Cited by
COVID-19 vaccine hesitancy in Africa: a scoping review
Ackah, B. B. B., Woo, M., Stallwood, L., Fazal, Z. A., Okpani, A., Ukah, U. V., & Adu, P. A. (2022) · Global Health Research and Policy · doi:10.1186/s41256-022-00255-1 · Cited by 217
Haeuser, E., Byrne, S., Nguyen, J., Raggi, C., McLaughlin, S. A., Bisignano, C., Harris, A. A., Smith, A. E., Lindstedt, P. A., Smith, G., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01037-2 · Cited by 143
Predictors of COVID-19 Vaccine Hesitancy in South African Local Communities: The VaxScenes Study
Katoto, P. D., Parker, S., Coulson, N., Pillay, N., Cooper, S., Jaca, A., Mavundza, E. J., Houston, G. F., Groenewald, C., Essack, Z., et al. (2022) · Vaccines · doi:10.3390/vaccines10030353 · Cited by 68
“Furthermore, in a survey of 5416 Africans, 37% of participants were hesitant to accept the COVID-19 immunization once available to them (with the highest level of hesitancy observed among participants from Central Africa; 67%), and 79% were concerned about its negative effects [52].”
BackgroundSelf-citationRomate, J., Rajkumar, E., Gopi, A., Abraham, J., Rages, J., Lakshmı, R., Jesline, J., & Bhogle, S. (2022) · Vaccines · doi:10.3390/vaccines10111777 · Cited by 72
“[92] Africa General population n = 5416 Serious side effects of vaccine”
BackgroundCOVID-19 vaccine inequity in African low-income countries
Kunyenje, C. A., Chirwa, G. C., Mboma, S. M., Ng’ambi, W. F., Mnjowe, E., Nkhoma, D., Ngwira, L. G., Chawani, M. S., Chilima, B., Mitambo, C., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1087662 · Cited by 56
“Among the top 10 HICs, COVID-19 vaccine coverage was highest in Qatar (105.75”
BackgroundInfluentialOgunleye, O. O., Godman, B., Fadare, J. O., Mudenda, S., Adeoti, A. O., Yinka-Ogunleye, A. F., Ogundele, S. O., Oyawole, M. R., Schönfeldt, M., Rashed, W. M., et al. (2022) · Vaccines · doi:10.3390/vaccines10091553 · Cited by 54
Naidoo, D., Meyer‐Weitz, A., & Govender, K. (2023) · Vaccines · doi:10.3390/vaccines11040873 · Cited by 44
“, drugs such as hydroxychloroquine, azithromycin, and ivermectin) [27] and negative past experiences with vaccines [40].”
BackgroundInfluentialShah, J., Abeid, A. M., Sharma, K., Manji, S., Nambafu, J., Korom, R., Patel, K. A., Said, M. H., Mohamed, M. A., Sood, M., et al. (2022) · Vaccines · doi:10.3390/vaccines10050705 · Cited by 42
“It was reported by other studies as well that, specifically in Africa, the cost of the vaccine may be associated with non-acceptance of the vaccine [15,30,43].”
BackgroundResultde Figueiredo, A., Temfack, E., Raji, T., & Larson, H. J. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2213117 · Cited by 39
Determinants of COVID-19 vaccine hesitancy and uptake in sub-Saharan Africa: a scoping review
Deml, M. J., & Githaiga, J. N. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-066615 · Cited by 42
“Anjorin et al , 67 for example, referenced a 2014 WHO’s SAGE report, 71 describing the ‘3Cs model’ which includes the concepts of confidence, complacency and convenience.”
BackgroundBarriers and facilitators of childhood COVID-19 vaccination among parents: A systematic review
Khan, Y. H., Rasheed, M., Mallhi, T. H., Salman, M., Alzarea, A. I., Alanazi, A. S., Alotaibi, N. H., Khan, S.-U.-D., Alatawi, A. D., Butt, M. H., et al. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.950406 · Cited by 38
“(105) Side effects 36 (9%) Financial instability, Distance to the healthcare center 350 (90%) Information obtained through healthcare workers”
BackgroundBabatope, T., Ilyenkova, V., & Marais, D. (2023) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-023-01017-w · Cited by 37
Baghani, M., Fathalizade, F., Loghman, A. H., Samieefar, N., Ghobadinezhad, F., Rashedi, R., Baghsheikhi, H., Sodeifian, F., Rahimzadegan, M., & Akhlaghdoust, M. (2023) · Science in One Health · doi:10.1016/j.soh.2023.100048 · Cited by 29
Siewchaisakul, P., Sarakarn, P., Nanthanangkul, S., Longkul, J., Boonchieng, W., & Wungrath, ๋. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270023 · Cited by 27
Miner, C. A., Timothy, C. G., Mashige, K. P., Mashige, Osuagwu, U. L., Envuladu, E. A., Amiebenomo, O. M.-A., Ovenseri-Ogbomo, G. O., Charwe, D. D., Goson, P. C., et al. (2023) · BMC Public Health · doi:10.1186/s12889-023-15116-w · Cited by 24
“This finding is different from that reported in a previous study [42] where a higher proportion of African residents and those in the diaspora were willing to accept the vaccine when offered.”
ResultGovender, K., Nyamaruze, P., McKerrow, N., Meyer‐Weitz, A., & Cowden, R. G. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2021-007839 · Cited by 24
Watermeyer, J., Scott, M., Kapueja, L., & Ware, L. J. (2022) · Health Policy and Planning · doi:10.1093/heapol/czac060 · Cited by 24
“and only 40% believed that vaccines should be mandatory (Anjorin et al., 2021).”
BackgroundPublic Health Surveillance for Adverse Events Following COVID-19 Vaccination in Africa
Anjorin, A. A., Odetokun, I. A., Nyandwi, J. B., Elnadi, H., Awiagah, S. K., Eyedo, J., Abioye, A. I., Gachara, G., Maisara, A. M., Razouqi, Y., et al. (2022) · Vaccines · doi:10.3390/vaccines10040546 · Cited by 25
“[15] on the use of a multi-channel vaccination campaign strategy is necessary for excellent vaccine uptakes.”
BackgroundSelf-citationEarly Impact of SARS-CoV-2 Pandemic on Immunization Services in Nigeria
Essoh, T.-A., Adeyanju, G. C., Adamu, A. A., Ahawo, A. K., Desquith, A. A., Tall, H., Aplogan, A., & Wiysonge, C. S. (2022) · Vaccines · doi:10.3390/vaccines10071107 · Cited by 19
Hesitação vacinal contra a COVID-19 na América Latina e África: uma revisão de escopo
Gonçalves, B. A., Matos, C. C. D. S. A., Ferreira, J. V. D. S., Itagyba, R. F., Moço, V. R., & Couto, M. T. (2023) · Cadernos de Saúde Pública · doi:10.1590/0102-311xpt041423 · Cited by 36
Olawa, B. D., Lawal, A. M., Odoh, I. M., Azikiwe, J. C., Olawole, A., Odusina, E. K., Ayodele, I. O., & Ajayi, O. (2023) · Journal of the Egyptian Public Health Association · doi:10.1186/s42506-023-00129-5 · Cited by 15
“In another survey of African countries, a 40% hesitancy rate was documented with 79% bothered about the unforeseen negative effects of vaccination [6].”
BackgroundAlam, Z., Mohamed, S. A. E. H., Nauman, J., Al‐Rifai, R. H., Ahmed, L. A., & Elbarazi, I. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2245720 · Cited by 15
Hicks, E. G., Kandel, S. E., & Lampe, J. N. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128732 · Cited by 12
COVID-19 Vaccine Hesitancy in 53 Developing Countries: Levels, Trends, and Reasons for Hesitancy
Eberwein, J. D., Edochie, I. N., Newhouse, D., Cojocaru, A., Deudibe, G., Kakietek, J. J., Kim, Y. S., & Montes, J. (2022) · World Bank, Washington, DC eBooks · doi:10.1596/1813-9450-10191 · Cited by 12
Volatility of the COVID-19 vaccine hesitancy: sentiment analysis conducted in Brazil
Machado, C., Mantovani, D. M. N., de Sandes-Guimarães, L. V., Romeiro, M. D. C., Furlaneto, C. J., & Bazanini, R. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1192155 · Cited by 8
“Residents of sub-Saharan Africa, for example, feared being victims of vaccine experimentation (43).”
BackgroundOdetokun, I. A., Oniyanda, O., Raza, A., Akpabio, U., Musawa, A. I., Hambali, I. U., Adamu, S. G., Oyafajo, L. A., Alhaji, N. B., & Fasina, F. O. (2024) · Discover Public Health · doi:10.1186/s12982-024-00195-w · Cited by 7
“KAP offers valuable insights into communities’ readiness to adopt preventive measures and compliance with health directives, impacting decisions on vaccination, hygiene, and social distancing that can be used in controlling pandemics [15–19].”
Self-citationAkel, K. B., Noppert, G. A., Rajamoorthy, Y., Lu, Y., Singh, A. K., Harapan, H., Chang, H., Zhang, F., Shih, S., & Wagner, A. L. (2022) · PLOS Global Public Health · doi:10.1371/journal.pgph.0000734 · Cited by 8
“Previous research has documented risk perceptions nevertheless are hugely impactful for vaccine rejection across African countries [40].”
BackgroundCOVID-19, Law & Regulation: Rights, Freedoms, and Obligations in a Pandemic
Bennett, B., Freckelton, I. R., & Wolf, G. (2023) · doi:10.1093/oso/9780192896742.001.0001 · Cited by 14
Eberwein, J. D., Edochie, I. N., Newhouse, D., Cojocaru, A., Deudibe, G., Kakietek, J. J., Kim, Y. S., & Montes, J. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-069152 · Cited by 11
Attitudes to Vaccine Mandates among Late Adopters of COVID-19 Vaccines in Zimbabwe
Makadzange, T., Gundidza, P. T., Lau, C., Dietrich, J. J., Beta, N., Myburgh, N., Elose, N., Ndhlovu, C. E., James, W., & Stanberry, L. R. (2022) · Vaccines · doi:10.3390/vaccines10071090 · Cited by 8
“actual behavior would have been challenging [13,22].”
BackgroundPadmanabhanunni, A., Pretorius, T. B., & Isaacs, S. A. (2023) · BMC Public Health · doi:10.1186/s12889-023-16803-4 · Cited by 9
“Anjorin and colleagues [12] in a survey of 34 countries in Africa reported that 63% of respondents were willing to receive the COVID19 vaccine, 79% were concerned about side effects, and 39% were worried about COVID-19 infection after receiving the vaccine.”
BackgroundPredictors of COVID-19 vaccine hesitancy in Chad: A cross-sectional study
Dzomo, G. R. T., Mbario, E., Djarma, O. M., Soumbatingar, N. S., Madengar, M., Djimera, N., Djindimadje, A., Nguemadjita, C., Nassaringar, G., Bernales, M., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1063954 · Cited by 6
“A comparable study found that 30% of Africans who reject the COVID-19 vaccine do so because they fear that the COVID-19 vaccine is being used as an excuse to “experiment” on Africans (18).”
BackgroundInfluentialMathematical model of voluntary vaccination against schistosomiasis
Lopez, S., Majid, S., Syed, R., Rychtář, J., & Taylor, D. (2024) · PeerJ · doi:10.7717/peerj.16869 · Cited by 9
Iliyasu, Z., Garba, R. M., Aliyu, M., Gajida, A. U., Amole, T. G., Umar, A. A., Abdullahi, H. M., Tsiga-Ahmed, F. I., Kwaku, A. A., Kowalski, M. S., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192113937 · Cited by 5
“Furthermore, among members of the public, the figures varied from 40% across Africa to 73% in Australia [12,13].”
BackgroundInfluentialPerceptions and knowledge of frontline health workers on emerging zoonotic diseases in Nigeria
Ghali-Mohammed, I., Usman, A. H., Aliyu, M. B., Akpabio, U., Odetokun, I. A., & Alhaji, N. B. (2025) · CABI One Health · doi:10.1079/cabionehealth.2025.0012 · Cited by 5
Self-citationAarslew, L. F., Haas, N., & Khadka, P. (2023) · Scientific Reports · doi:10.1038/s41598-023-48389-7 · Cited by 4
Babicki, M., Malchrzak, W., & Mastalerz–Migas, A. (2022) · Vaccines · doi:10.3390/vaccines10030381 · Cited by 5
“Despite the emergence of many studies that indicate both the high efficacy and safety profile of COVID-19 vaccines, a high level of these concerns is still observed, not only in Poland but also worldwide [8,9].”
BackgroundPublic Attitudes Towards COVID-19 Vaccination: A Cross-Sectional Study in Iran
Darrudi, A., Sari, A. A., Yunesian, M., & Daroudi, R. (2023) · Health Scope · doi:10.5812/jhealthscope-134323 · Cited by 4
“Studies whose participants were the general population from China (16), the United States (12), Indonesia (11), Ecuador (17), and Africa (18) report acceptability rates of 63 - 97%.”
BackgroundResultInfluentialUptake of public health measures and vaccine acceptance during the COVID-19 pandemic in rural Zambia
Sutcliffe, C. G., Sinywimaanzi, P., Morales, J. A., Sianyanda, M., Muleka, M., Fenstermacher, K., Monze, M., Rothman, R. E., Pekosz, A. S., Thuma, P. E., et al. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2153538 · Cited by 4
“to the safety and side effects of the vaccine, which is consistent with other studies in the region.(17,18,20) Myths and misinforma-”
BackgroundResultNyamuryekung’e, K. K., Amour, M. A., Mboya, I. B., Ndumwa, H. P., Kengia, J. T., Njiro, B. J., Mhamilawa, L. E., Shayo, E. H., Ngalesoni, F. N., Kapologwe, N., et al. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0001223 · Cited by 7
Eyal, K. C., Njozela, L., Köhler, T., Ingle, K., Brophy, T. S., Buttenheim, A. M., & Maughan‐Brown, B. (2023) · BMC Public Health · doi:10.1186/s12889-023-16584-w · Cited by 5
“The latter characteristic is typical of telephone [18] and online surveys [9, 12, 24, 34, 35], and was expected given the sampling frame [35].”
BackgroundResultInfluentialMsuya, H. M., Mrisho, G. A., Mkopi, A., Mrisho, M., Lweno, O., Ali, A. M., Said, A. H., Mihayo, M., Mswata, S., Tumbo, A., et al. (2023) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.23-0229 · Cited by 6
“28 In Tanzania, little is known about COVID-19 vaccine hesitancy.”
COVID-19 Vaccine Hesitancy Among Older Adults in a Geriatric Centre in Nigeria
Adebusoye, L. A., Cadmus, E., Oyinlola, O., & Obadare, A. (2023) · Cureus · doi:10.7759/cureus.51102 · Cited by 4
“In addition, the link between lower education levels and heightened vaccine hesitancy aligns with broader patterns observed in vaccine hesitancy empirical evidence, where individuals with limited access to information and education are more susceptible to misinformation and distrust [15,26].”
BackgroundResultInfluentialDrivers of COVID-19 vaccine uptake among rural populations in Madagascar: a cross-sectional study
Kislaya, I., Andrianarimanana, D. K., Marchese, V., Hosay, L., Rakotonavalona, R., Ramananjanahary, H., Rasamoelina, T., Zafinimampera, A. O., Ratefiarisoa, S., Totofotsy, O., et al. (2024) · BMC Public Health · doi:10.1186/s12889-024-20414-y · Cited by 4
“In fact, having access to free vaccines has been recognized by the populations as a desirable feature of vaccination campaigns in 34 African countries [30].”
BackgroundMakadzange, T., Lau, C., Dietrich, J., Hlupeni, A., Myburgh, N., Gundidza, P., Elose, N., Madhi, S. A., James, W., Stanberry, L., et al. (2023) · Vaccines · doi:10.3390/vaccines11020411 · Cited by 6
“However, by early 2022, Africa had less than 15% vaccine coverage with vaccine hesitancy being an important driver of low coverage rates [15].”
BackgroundBennett, B., Freckelton, I. R., & Wolf, G. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.003.0004 · Cited by 3
Makadzange, T., Lau, C., Dietrich, J. J., Hlupeni, A., Myburgh, N., Gundidza, P., Elose, N., Mahdi, S., James, W., Stanberry, L., et al. (2022) · medRxiv · doi:10.1101/2022.04.20.22274081 · Cited by 3
Predictors of willingness to accept COVID-19 vaccine among adults
Edin, A., Alemeyehu, L., Boneya, D. J., Ayele, A., & Shifa, T. (2023) · Frontiers in Epidemiology · doi:10.3389/fepid.2023.1240557 · Cited by 2
“In Africa around 63% of all participants surveyed were eager to accept the COVID-19 vaccine (13).”
BackgroundAdebowale, O. O., Adenubi, O. T., Adesokan, H. K., Oloye, A. A., Bankole, N. O., Fadipe, O., Ayo-Ajayi, P. O., & Akinloye, O. (2022) · Sokoto Journal of Veterinary Sciences · doi:10.4314/sokjvs.v20i2.8 · Cited by 2
Olarewaju, S. O., Jegede, O. S., Ijitade, G., & Akande, A. M. (2022) · International Journal of Medicine and Health Development · doi:10.4103/ijmh.ijmh_18_22 · Cited by 1
Adigwe, O. P., & Onavbavba, G. (2024) · PLOS Global Public Health · doi:10.1371/journal.pgph.0002589 · Cited by 2
“Vaccine hesitancy stems from multiple factors including lack of confidence and issues associated with complacency and convenience [20].”
BackgroundOnyeaghala, A. A., Anyiam, A. F., Husaini, D. C., Chiroma, J. H., & Arinze-Anyiam, O. C. (2025) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2025.101016 · Cited by 2
Abeje, E. T., Enyew, E. B., Daba, C., Asmare, L., Bayou, F. D., Arefaynie, M., Mohammed, A., Tareke, A. A., Keleb, A., Kebede, N., et al. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1521602 · Cited by 2
Asasah, S. I., Imade, E. E., & Enagbonma, B. J. (2025) · Journal of Public Health · doi:10.1093/pubmed/fdaf071 · Cited by 1
Sujarwoto, S., & Maharani, A. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1203550 · Cited by 1
Edin, A., Alemeyehu, L., Boneya, D. J., Ayele, A., & Shifa, T. (2023) · Research Square · doi:10.21203/rs.3.rs-2747153/v1 · Cited by 1
Papelian, S. (2025) · Research Square · doi:10.21203/rs.3.rs-7340665/v1 · Cited by 2
Miner, C. A., Timothy, C. G., Mashige, K. P., Osuagwu, U. L., Envuladu, E. A., Amiebenomo, O. M.-A., Ovenseri-Ogbomo, G. O., Charwe, D. D., Goson, P. C., Ekpenyong, B. N., et al. (2022) · medRxiv · doi:10.1101/2022.03.16.22272510
Increasing COVID-19 Vaccine Uptake in Africa
El-Kour, T. (2022) · doi:10.19088/k4d.2022.099
Kim, Y., Woo, W., Kipkorir, V., Rahmati, M., Yon, D. K., Lee, S. W., Koyanagi, A., Shin, J. I., & Smith, L. (2022) · Research Square · doi:10.21203/rs.3.rs-1998674/v1
Criminal Justice Issues and the COVID-19 Pandemic
Bennett, B., Freckelton, I. R., & Wolf, G. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.003.0008
Litigation and Legal Challenges to Emergency Orders
Bennett, B., Freckelton, I. R., & Wolf, G. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.003.0006
Production, Regulation, and Distribution of COVID-19 Treatments and Vaccines
Bennett, B., Freckelton, I. R., & Wolf, G. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.003.0012
Gostin, L. O. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.002.0006
Risk, Impact, and Disadvantage
Bennett, B., Freckelton, I. R., & Wolf, G. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.003.0007
Bennett, B., Freckelton, I. R., & Wolf, G. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.003.0001
Bennett, B., Freckelton, I. R., & Wolf, G. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.002.0008
Bennett, B., Freckelton, I. R., & Wolf, G. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.002.0009
Past Legal and Regulatory Responses to Infectious Diseases
Bennett, B., Freckelton, I. R., & Wolf, G. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.003.0002
Domestic Laws and Emergency Measures
Bennett, B., Freckelton, I. R., & Wolf, G. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.003.0005
Law, Regulation, and Rights: Reflections on the COVID-19 Pandemic
Bennett, B., Freckelton, I. R., & Wolf, G. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.003.0013
Bennett, B., Freckelton, I. R., & Wolf, G. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.002.0011
Bennett, B., Freckelton, I. R., & Wolf, G. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.003.0003
Bennett, B., Freckelton, I. R., & Wolf, G. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.002.0010
Bennett, B., Freckelton, I. R., & Wolf, G. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.002.0004
Bennett, B., Freckelton, I. R., & Wolf, G. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.002.0003
Civil Liability, Regulation, and Accountability
Bennett, B., Freckelton, I. R., & Wolf, G. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.003.0009
Bennett, B., Freckelton, I. R., & Wolf, G. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.002.0005
COVID-19 and Workplace and Occupational Health and Safety
Bennett, B., Freckelton, I. R., & Wolf, G. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.003.0010
Development of COVID-19 Treatments and Vaccines
Bennett, B., Freckelton, I. R., & Wolf, G. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780192896742.003.0011
Elnadi, H., Al-Mustapha, A. I., Odetokun, I. A., Anjorin, A. A., Mosbah, R., Fasina, F. O., Razouqi, Y., Awiagah, S. K., Nyandwi, J. B., Mhgoob, Z. E., et al. (2023) · medRxiv · doi:10.1101/2023.06.22.23291768
Self-citationAnin, S. K., & Krämer, A. (2023) · Medizin, Kultur, Gesellschaft · doi:10.1007/978-3-658-40525-0_23
Yakasai, H. B., Lasisi, M. D., Uwha, E. P., Chukwu, I. S., Akinde, C., Fasiku, M. M., Abdullah, U. I., Bojuwoye, M. O., Izuka, M., Ugwu, E. O., et al. (2024) · Acta Scientific Women s Health · doi:10.31080/aswh.2024.06.0588
Daniel, E. O., Olawale, O. O., Bello, A. M., Tomori, M. O., Avwerhota, M., Popoola, I. O., Ogun, A. A., Popoola, T. A., Salami, A., Alewi, O. O., et al. (2024) · European Journal of Preventive Medicine · doi:10.11648/j.ejpm.20241203.12
Predictors of COVID-19 Vaccine Hesitancy in North-Central Nigeria
Olutola, A., Gobir, I. B., Bazira, D., Agboola, S., Sanni, F. O., Bello, A. A., Havila, N. O., Adamu, A., Bello, F., Otubo, S. A., et al. (2024) · Journal of Immunization · doi:10.14302/issn.2577-137x.ji-24-5207 · Cited by 1
Akhtar, M. A., Khan, K. A., Fatima, S., & Tripathi, P. K. (2024) · Journal of Health Management · doi:10.1177/09720634241278813
Etuk, V., Sanni, C., Omonijo, O., Atema, S. I., Lawal, T. V., Yashim-Ankut, A. M., Ejinkeonye, I., Onyegbutulem, H. C., Oyedele, O. K., Williams, I., et al. (2024) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trae094
Aina, F., & Adeleke, A. (2025) · Springer eBooks · doi:10.1007/978-3-031-82892-8_6
Onuekwe, C. E., Mathenge, V. W., Makulilo, A. B., Mwengee, W., Haonga, T., Saguti, G., & Sagoe-Moses, C. (2025) · Journal of Public Health in Africa · doi:10.4102/jphia.v16i3.702
“15 The study showed that Tanzanians (91 % ) are knowledgeable about the dangers of COVID-19 and are willing to be vaccinated, yet few visited any health facility for COVID-19 vaccination.”
Additional file 1 of COVID-19 vaccine hesitancy in Africa: a scoping review
Ackah, B., Woo, M., Stallwood, L., Fazal, Z. A., Okpani, A., Ukah, U. V., & Adu, P. A. (2022) · Figshare · doi:10.6084/m9.figshare.20336906
Morillon, G. F., Guillon, M., & Mathonnat, J. (2026) · The International Journal of Health Planning and Management · doi:10.1002/hpm.70058 · Cited by 1
Sun, J., Cao, Y., Grépin, K. A., Li, T., Chen, H., Zhao, Q., & Chi, P. C. (2026) · Journal of Global Health · doi:10.7189/jogh.16.04143
Njakoi, C. K., Owajege, C. N., & Wirsiy, F. S. (2026) · Discover Public Health · doi:10.21203/rs.3.rs-9455647/v1
Aung, T. N., Muyindike, W. R., Hoeppner, S. S., Nanfuka, V., Komukama, N., Barigye, I. T., Tumusiime, J., Omoding, D., Johnson, L. S., Stuckwisch, A. M., et al. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128912
Metadata
- Authors
- Anjorin, A. A., Odetokun, I. A., Abioye, A. I., Elnadi, H., Umoren, M. V., Damaris, B. F., Eyedo, J., Umar, H. I., Nyandwi, J. B., Abdalla, M. M., Tijani, S. O., Awiagah, K. S., Idowu, G. A., Fabrice, S. N. A., Maisara, A. M. O., Razouqi, Y., Mhgoob, Z. E., Parker, S., Asowata, O. E., Adesanya, I. O., Obara, M. A., Jaumdally, S., Kitema, G. F., Okuneye, T. A., Mbanzulu, K. M., Daitoni, H., Hallie, E. F., Mosbah, R., & Fasina, F. O.
- Affiliations
- Lagos State University (NG)
- University of Ilorin (NG)
- Harvard University (US)
- Université de Tours (FR)
- Cincinnati Children's Hospital Medical Center (US)
- Medizinische Hochschule Hannover (DE)
- Federal University of Technology (NG)
- Gyeongsang National University (KR)
- Minia University Hospital (EG)
- University of Lagos (NG)
- International University of Africa (SD)
- Université Sultan Moulay Slimane (MA)
- Al-Neelain University (SD)
- University of Cape Town (ZA)
- Africa Health Research Institute (ZA)
- University of St Andrews (GB)
- General Hospital Lagos, Odan (NG)
- University of Kinshasa (CD)
- University of Liberia (LR)
- Zagazig University (EG)
- Food and Agriculture Organization of the United Nations (IT)
- Corresponding author
- Fasina, Folorunso O.
- ORCID
- Anjorin, AbdulAzeez A.
- Odetokun, Ismail A.
- Abioye, Ajibola I.
- Eyedo, Joseph
- Umar, Haruna I.
- Nyandwi, Jean B.
- Abdalla, Mena M.
- Tijani, Sodiq O.
- Idowu, Gbolahan A.
- Fabrice, Sifeuh N. Achille
- Razouqi, Youssef
- Parker, Salim
- Asowata, Osaretin E.
- Jaumdally, Shameem
- Kitema, Gatera F.
- Mbanzulu, Kennedy M.
- Mosbah, Rasha
- Fasina, Folorunso O.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-12-01
- Volume
- 16
- Issue
- 12
- Pages
- e0260575
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC8635331
- OpenAlex
- W3217193330
- Cited by
- 94
- References
- 35
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 9 · 2023: 47 · 2022: 26
- FWCI
- 11.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- public-domain
- creativecommons.org/publicdomain/zero/1.0/ (vor)
- Locations
- PLoS ONE (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Edinburgh Napier Research Repository (Edinburgh Napier University) (publishedVersion, public-domain)
- UpSpace Institutional Repository (University of Pretoria) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- St Andrews Research Repository (St Andrews Research Repository) (submittedVersion, cc-by)
- Topics
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Keywords
- COVID-19 vaccine hesitancy, COVID-19 vaccination, vaccine willingness, vaccine side effects, perceived infection risk, vaccine literacy, vaccine affordability, mandatory vaccination, vaccine distribution, Africa
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Vaccines, Adolescent, Adult, Aged, Cross-Sectional Studies, Female, Health Status, Humans, Male, Middle Aged, Surveys and Questionnaires, Vaccination, Knowledge, Black People, Young Adult, Health Literacy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
